CARMEN GRIÑÁN LISÓN-rekin lankidetzan egindako argitalpenak (32)

2024

  1. Autologous patient-derived exhausted nano T-cells exploit tumor immune evasion to engage an effective cancer therapy

    Molecular Cancer, Vol. 23, Núm. 1

  2. Mimicking the Tumor Niche: Methods for Isolation, Culture, and Characterization of Cancer Stem Cells and Multicellular Spheroids

    Methods in molecular biology (Clifton, N.J.), Vol. 2777, pp. 145-161

  3. Unlocking the effective alliance of β-lapachone and hydroxytyrosol against triple-negative breast cancer cells

    Biomedicine and Pharmacotherapy, Vol. 174

2023

  1. Interferon-Alpha Decreases Cancer Stem Cell Properties and Modulates Exosomes in Malignant Melanoma

    Cancers, Vol. 15, Núm. 14

  2. New ICT-Based Ratiometric Two-Photon near Infrared Probe for Imaging Tyrosinase in Living Cells, Tissues, and Whole Organisms

    Chemosensors, Vol. 11, Núm. 2

  3. Ratiometric Two-Photon Near-Infrared Probe to Detect DPP IV in Human Plasma, Living Cells, Human Tissues, and Whole Organisms Using Zebrafish

    ACS Sensors, Vol. 8, Núm. 3, pp. 1064-1075

  4. TGFβ Governs the Pleiotropic Activity of NDRG1 in Triple-Negative Breast Cancer Progression

    International Journal of Biological Sciences, Vol. 19, Núm. 1, pp. 204-224

  5. Unraveling the Potential of miRNAs from CSCs as an Emerging Clinical Tool for Breast Cancer Diagnosis and Prognosis

    International Journal of Molecular Sciences, Vol. 24, Núm. 21

2022

  1. EZH2 endorses cell plasticity to non-small cell lung cancer cells facilitating mesenchymal to epithelial transition and tumour colonization

    Oncogene, Vol. 41, Núm. 28, pp. 3611-3624

  2. Nanomedicine as a Promising Tool to Overcome Immune Escape in Breast Cancer

    Pharmaceutics, Vol. 14, Núm. 3

2021

  1. Antioxidants for the treatment of breast cancer: Are we there yet?

    Antioxidants, Vol. 10, Núm. 2, pp. 1-44

  2. Development of a Biomimetic Hydrogel Based on Predifferentiated Mesenchymal Stem-Cell-Derived ECM for Cartilage Tissue Engineering

    Advanced Healthcare Materials, Vol. 10, Núm. 8

2020

  1. CSC Radioresistance: A Therapeutic Challenge to Improve Radiotherapy Effectiveness in Cancer

    Cells, Vol. 9, Núm. 7

  2. Cancer stem cell secretome in the tumor microenvironment: a key point for an effective personalized cancer treatment

    Journal of Hematology and Oncology, Vol. 13, Núm. 1

  3. Deregulation of cancer-stem-cell-associated miRNAs in tissues and sera of colorectal cancer patients

    Oncotarget, Vol. 11, Núm. 2, pp. 116-130

  4. Matrix metalloproteases and TIMPs as prognostic biomarkers in breast cancer patients treated with radiotherapy: A pilot study

    Journal of Cellular and Molecular Medicine, Vol. 24, Núm. 1, pp. 139-148

  5. The inhibitory role of mir-486-5p on csc phenotype has diagnostic and prognostic potential in colorectal cancer

    Cancers, Vol. 12, Núm. 11, pp. 1-24

  6. miRNAs as radio-response biomarkers for breast cancer stem cells

    Molecular Oncology, Vol. 14, Núm. 3, pp. 556-570

2019

  1. Deciphering the mechanism of action involved in enhanced suicide gene colon cancer cell killer effect mediated by gef and apoptin

    Cancers, Vol. 11, Núm. 2

  2. GENYOi005-A: An induced pluripotent stem cells (iPSCs) line generated from a patient with Familial Platelet Disorder with associated Myeloid Malignancy (FPDMM) carrying a p.Thr196Ala variant

    Stem Cell Research, Vol. 41